Skip to Primary Navigation

Fujifilm blazes a trail through pharma’s ethical quagmire

Clinician wearing personal protective equipment while injecting something into an egg.
Photo: Smith Collection/Gado/Getty Images

As advancements in research and drug development become more complex, bioethicists are helping companies find their footing along an increasingly ambiguous path.

The pharmaceutical industry resides on a terrain riddled with ethical landmines across research, product development, AI-enabled technologies, manufacturing, and commercialization over which pharma, biotech, and other life sciences companies must tread lightly. 

Fujifilm Holdings America Corporation recognized it was no exception and decided to take a proactive